Literature DB >> 7698995

Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains.

A Hémar1, A Subtil, M Lieb, E Morelon, R Hellio, A Dautry-Varsat.   

Abstract

Members of the cytokine receptor family are composed of several noncovalently linked chains with sequence and structure homologies in their extracellular domain. Receptor subfamily members share at least one component: thus the receptors for interleukin (IL) 2 and IL15 have common beta and gamma chains, while those for IL2, 4, 7, and 9 have a common gamma chain. The intracellular pathway followed by IL2 receptors after ligand binding and endocytosis was analyzed by immunofluorescence and confocal microscopy in a human T lymphocytic cell line. Surprisingly, the alpha, beta, and gamma chains had different intracellular localizations after being endocytosed together. The alpha chain was always in transferrin-positive compartments (early/recycling endosomes), both at early and late internalization times, but was never detected in rab7-positive compartments (late endosomes). On the other hand, at late internalization times, the beta and gamma chains were excluded from transferrin-positive organelles and did not colocalize with alpha. Furthermore, beta could be found in rab7-positive vesicles. These differences suggest that the alpha chain recycles to the plasma membrane, while the beta and gamma chains are sorted towards the degradation pathway. The half-lives of these three chains on the cell surface also reflect their different intracellular fates after endocytosis. The beta and gamma chains are very short-lived polypeptides since their half-life on the surface is only approximately 1 h, whereas alpha is a much more stable surface protein. This shows for the first time that components of a multimeric receptor can be sorted separately along the endocytic pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7698995      PMCID: PMC2120376          DOI: 10.1083/jcb.129.1.55

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  60 in total

Review 1.  Signal-dependent membrane protein trafficking in the endocytic pathway.

Authors:  I S Trowbridge; J F Collawn; C R Hopkins
Journal:  Annu Rev Cell Biol       Date:  1993

2.  Cloning of the gamma chain of the human IL-2 receptor.

Authors:  T Takeshita; H Asao; K Ohtani; N Ishii; S Kumaki; N Tanaka; H Munakata; M Nakamura; K Sugamura
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

3.  Interleukin-2 (IL-2) receptor gamma chain mutations in X-linked severe combined immunodeficiency disease result in the loss of high-affinity IL-2 receptor binding.

Authors:  J P DiSanto; A Dautry-Varsat; S Certain; A Fischer; G de Saint Basile
Journal:  Eur J Immunol       Date:  1994-02       Impact factor: 5.532

4.  The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation.

Authors:  K S Ravichandran; S J Burakoff
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

5.  High-affinity interleukin 2 receptor alpha and beta chains are internalized and remain associated inside the cells after interleukin 2 endocytosis.

Authors:  V Duprez; M Ferrer; A Dautry-Varsat
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

6.  Both the alpha and beta chains of high-affinity interleukin 2 receptors are located in intracellular vesicles when their ligand is endocytosed.

Authors:  M Ferrer; A Hémar; V Duprez; R Hellio; A Dautry-Varsat
Journal:  Eur J Cell Biol       Date:  1993-04       Impact factor: 4.492

7.  Interleukin 2-induced activation of Ras requires two domains of interleukin 2 receptor beta subunit, the essential region for growth stimulation and Lck-binding domain.

Authors:  T Satoh; Y Minami; T Kono; K Yamada; A Kawahara; T Taniguchi; Y Kaziro
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

8.  Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4.

Authors:  M Kondo; T Takeshita; N Ishii; M Nakamura; S Watanabe; K Arai; K Sugamura
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

9.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor.

Authors:  S M Russell; A D Keegan; N Harada; Y Nakamura; M Noguchi; P Leland; M C Friedmann; A Miyajima; R K Puri; W E Paul
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

10.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor.

Authors:  M Noguchi; Y Nakamura; S M Russell; S F Ziegler; M Tsang; X Cao; W J Leonard
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

View more
  63 in total

1.  Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments.

Authors:  A Rocca; C Lamaze; A Subtil; A Dautry-Varsat
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 2.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Authors:  Thomas R Malek; Iris Castro
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

Review 3.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

4.  IL-7 induces clathrin-mediated endocytosis of CD127 and subsequent degradation by the proteasome in primary human CD8 T cells.

Authors:  Elliott M Faller; Feras M Ghazawi; Marko Cavar; Paul A MacPherson
Journal:  Immunol Cell Biol       Date:  2015-08-14       Impact factor: 5.126

Review 5.  Some assembly required: putting the epithelial sodium channel together.

Authors:  Michael B Butterworth; Ora A Weisz; John P Johnson
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

6.  The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15Ralpha function but is not required for trans-presentation.

Authors:  Zheng Wu; Hai-Hui Xue; Jérôme Bernard; Rong Zeng; Dmitry Issakov; Julie Bollenbacher-Reilley; Igor M Belyakov; Sangkon Oh; Jay A Berzofsky; Warren J Leonard
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

7.  Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps.

Authors:  Suman Mitra; Aaron M Ring; Shoba Amarnath; Jamie B Spangler; Peng Li; Wei Ju; Suzanne Fischer; Jangsuk Oh; Rosanne Spolski; Kipp Weiskopf; Holbrook Kohrt; Jason E Foley; Sumati Rajagopalan; Eric O Long; Daniel H Fowler; Thomas A Waldmann; K Christopher Garcia; Warren J Leonard
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

8.  IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapy.

Authors:  Ee W Su; Caitlin J Moore; Samantha Suriano; Christopher Bryce Johnson; Neizel Songalia; Alicia Patterson; Daniel J Neitzke; Kristina Andrijauskaite; Elizabeth Garrett-Mayer; Shikhar Mehrotra; Chrystal M Paulos; Andrew L Doedens; Ananda W Goldrath; Zihai Li; David J Cole; Mark P Rubinstein
Journal:  Sci Transl Med       Date:  2015-10-28       Impact factor: 17.956

9.  Multiple endocytic signals in the C-terminal tail of the cystic fibrosis transmembrane conductance regulator.

Authors:  W Hu; M Howard; G L Lukacs
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

10.  The basis of distinctive IL-2- and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell development.

Authors:  Iris Castro; Aixin Yu; Michael J Dee; Thomas R Malek
Journal:  J Immunol       Date:  2011-10-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.